Cancer, Breast Clinical Trials

9 recruiting

Cancer, Breast Trials at a Glance

14 actively recruiting trials for cancer, breast are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Miami, Atlanta, and Aurora. Lead sponsors running cancer, breast studies include Beaumont Hospital, Centre Hospitalier de Valence, and AC Camargo Cancer Center.

Browse cancer, breast trials by phase

Treatments under study

About Cancer, Breast Clinical Trials

Looking for clinical trials for Cancer, Breast? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cancer, Breast trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cancer, Breast clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Not Applicable

Survivors Uniting for Remote Guided Exercise

CancerCancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)Physical Activity+4 more
Colorado State University300 enrolled1 locationNCT07290309
Recruiting
Phase 2

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

Breast CancerBreast CarcinomaBreast Neoplasm+34 more
University of California, Davis86 enrolled1 locationNCT06268665
Recruiting
Not Applicable

With Love, Grandma ("Con Cariño, Abuelita") Pilot Study

ObesityCancer, BreastCancer, Uterus+3 more
University of Miami Sylvester Comprehensive Cancer Center60 enrolled1 locationNCT05721976
Recruiting
Not Applicable

Evaluation of Wellbeing and Patient Reported Outcomes After Open vs Robotic Mastectomy With DIEP Reconstruction

Breast ReconstructionDIEP Flap Breast ReconstructionBreast Cancer, Breast Neoplasms+1 more
Beaumont Hospital250 enrolled1 locationNCT07230535
Recruiting
Not Applicable

Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery

Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)
AC Camargo Cancer Center164 enrolled1 locationNCT07268846
Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

CancerCancer, BreastCarcinoma+19 more
Massive Bio, Inc.50,000 enrolled68 locationsNCT03452774
Recruiting
Not Applicable

Evaluation of the Medical Service by Socio-aesthetics in Oncology

Cancer, BreastCancer of ColonCancer, Lung+3 more
Centre Hospitalier de Valence400 enrolled3 locationsNCT06035731
Recruiting
Not Applicable

Exercise in Triple- Negative Breast Cancer

Cancer, Breast
Technical University of Munich120 enrolled2 locationsNCT06672120
Recruiting
Not Applicable

Unified Barlow Protocol (UP) in Cancer Survivors for Cognitive Impairments

Cancer, Breast
Universidad de Córdoba123 enrolled2 locationsNCT05289258
Recruiting
Not Applicable

Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)

CardiotoxicityCancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)Elderly+1 more
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León514 enrolled14 locationsNCT03711110
Recruiting

Older Breast Cancer Patients: Risk for Cognitive Decline

Cancer, BreastAge-related Cognitive DeclineCognitive Decline
Georgetown University1,700 enrolled1 locationNCT03451383
Recruiting

Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients

Breast CancerMetastatic Breast CancerBreast Neoplasms+1 more
Sunnybrook Health Sciences Centre25 enrolled1 locationNCT04608357
Recruiting
Not Applicable

FAST-FORWARD vs HAI5

Cancer, Breast
University Hospital, Ghent740 enrolled2 locationsNCT06345534
Recruiting

Utilization of 5HTT gene polymorphism as a prognostic indicator in cancer

cancer. We are recruiting patients with a known primary cancer of the following types: lymphoma, lung, gastrointestinal tumours, genitourinary tumours, hepatocellular cancer, breast, nasopharyngeal cancers). Adjustment for cancer type in the statisticall analysis will be done by including cancer type in the regression model.
University of Alexandria300 enrolled1 locationACTRN12610000028000